Cardinal Health (CAH) PT Lowered to $56 at RBC Capital
RBC Capital lowered its price target on Cardinal Health (NYSE: CAH) to $56.00 (from $61.00) while maintaining a Sector Perform rating.
Analyst George Hill said the near-term outlook sees more challenges than opportunities.